×

We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

Bengaluru — The US government has signed a $450m contract with Regeneron Pharmaceuticals for its potential Covid-19 antibody cocktail.

The agreement, the first by the Trump administration to support a therapy, comes under the government’s “operation warp speed” programme aimed at faster distribution of vaccines and treatments to fight the new coronavirus when trials are successful...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now

Would you like to comment on this article?
Register (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.

Commenting is subject to our house rules.